Carasent Asa Stock EBITDA
| CARA Stock | 20.60 1.05 5.37% |
Carasent ASA fundamentals help investors to digest information that contributes to Carasent ASA's financial success or failures. It also enables traders to predict the movement of Carasent Stock. The fundamental analysis module provides a way to measure Carasent ASA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Carasent ASA stock.
Carasent |
Carasent ASA Company EBITDA Analysis
Carasent ASA's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Carasent ASA EBITDA | 27.72 M |
Most of Carasent ASA's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Carasent ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Carasent ASA reported earnings before interest,tax, depreciation and amortization of 27.72 M. This is 96.84% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The ebitda for all Norway stocks is 99.29% higher than that of the company.
Carasent EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Carasent ASA's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Carasent ASA could also be used in its relative valuation, which is a method of valuing Carasent ASA by comparing valuation metrics of similar companies.Carasent ASA is currently under evaluation in ebitda category among its peers.
Carasent Fundamentals
| Return On Equity | 0.0392 | |||
| Return On Asset | 0.0035 | |||
| Profit Margin | 0.26 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 627.64 M | |||
| Shares Outstanding | 79.62 M | |||
| Shares Owned By Insiders | 16.26 % | |||
| Shares Owned By Institutions | 33.30 % | |||
| Price To Book | 1.10 X | |||
| Price To Sales | 8.00 X | |||
| Revenue | 137.12 M | |||
| Gross Profit | 112.9 M | |||
| EBITDA | 27.72 M | |||
| Net Income | (148 K) | |||
| Book Value Per Share | 15.47 X | |||
| Cash Flow From Operations | 32.48 M | |||
| Earnings Per Share | 0.61 X | |||
| Target Price | 37.0 | |||
| Number Of Employees | 153 | |||
| Beta | 1.06 | |||
| Market Capitalization | 1.33 B | |||
| Total Asset | 1.3 B | |||
| Net Asset | 1.3 B |
About Carasent ASA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Carasent ASA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Carasent ASA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Carasent ASA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Carasent Stock
Carasent ASA financial ratios help investors to determine whether Carasent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carasent with respect to the benefits of owning Carasent ASA security.